Tissue transglutaminase activity protects from cutaneous melanoma metastatic dissemination: An in vivo study

Amino Acids

Volumn 44, Issue 1, 2013, Pages 53-61

  Facchiano, Francesco ^a   D'Arcangelo, Daniela ^b   Lentini, Alessandro ^c   Rossi, Stefania ^a   Senatore, Cinzia ^a   Pannellini, Tania ^e   Tabolacci, Claudio ^c   Facchiano, Angelo M ^d   Facchiano, Antonio ^b   Beninati, Simone ^c  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b LABORATORIO DI PATOLOGIA VASCOLARE   (Italy)

^c UNIVERSITY OF ROME TOR VERGATA   (Italy)

^d CNR   (Italy)

^e UNIVERSITY OF CHIETI   (Italy)

Author keywords

Bioinformatics; Cell proteome; Cutaneous melanoma; Microenvironment; Transglutaminase type 2

Indexed keywords

COMPLEMENTARY DNA; PLASMID DNA; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER GROWTH; CANCER MODEL; CANCER SIZE; CANCER SURVIVAL; CELL DIFFERENTIATION; CELL LYSATE; CELL PROLIFERATION; CONTROLLED STUDY; CUTANEOUS MELANOMA; DISEASE ACTIVITY; ENZYME ACTIVITY; ENZYME SUBSTRATE; HUMAN; HUMAN CELL; IN VIVO STUDY; KERATINOCYTE; LUNG METASTASIS; MALE; MELANOMA B16; METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEOMICS; SURVIVAL TIME; TRANSCRIPTOMICS;

ANIMALS; CASE-CONTROL STUDIES; CELL LINE, TUMOR; GENE EXPRESSION; HUMANS; KERATINOCYTES; LUNG NEOPLASMS; MALE; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; NEOPLASM TRANSPLANTATION; PROTEOME; SKIN NEOPLASMS; TRANSGLUTAMINASES;

MURINAE; MUS;

EID: 84871950063     PISSN: 09394451     EISSN: 14382199     Source Type: Journal    
DOI: 10.1007/s00726-012-1351-6     Document Type: Article

References (39)

1. Aguzzi MS, Facchiano F, Ribatti D, Gaeta R, Casadio R, Rossi I, Capogrossi MC, Facchiano A (2004) A novel RGDS-analog inhibits angiogenesis in vitro and in vivo. Biochem Biophys Res Commun 321(4):809-814
2. Albini A, Iwamoto Y, Kleinman HK (1987) A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res 47:3239-3245
3. Beninati S (1995) Post-translational modification of protein in cancer cells: the transglutaminase-catalyzed reaction (editorial). Cancer J 8:234-236
4. Beninati S, Abbruzzese A, Cardinali M (1993) Differences in the post-translational modification of proteins by polyamines between weakly and highly metastatic B16 melanoma cells. Int J Cancer 53:792-797
5. Bergamini CM, Eckert RL, Ichinose A, Muszbek L, Squerzanti M (2003) Cellular differentiation and death in a renaissance castle. Cell Death Differ 10(2):262-265
6. Blank CU, Hooijkaas AI, Haanen JB, Schumacher TN (2011) Combination of targeted therapy and immunotherapy in melanoma. Cancer Immunol Immunother 60(10):1359-1371
7. Brown ER, Doig T, Anderson N, Brenn T, Doherty V, Xu Y, Bartlett JM, Smyth JF, Melton DW (2012) Association of galectin-3 expression with melanoma progression and prognosis. Eur J Cancer 48(6):865-874
8. Chhabra A, Verma A, Mehta K (2009) Tissue transglutaminase promotes or suppresses tumors depending on cell context. Anticancer Res 29(6):1909-1919
9. Di Giacomo G, Lentini A, Beninati S, Piacentini M, Rodolfo C (2009) In vivo evaluation of type 2 transglutaminase contribution to the metastasis formation in melanoma. Amino Acids 36(4):717-724
10. Facchiano A, Facchiano F (2009) Transglutaminases and their substrates in biology and human diseases: 50 years of growing. Amino Acids 36(4):599-614
11. Facchiano F, D'Arcangelo D, Riccomi A, Lentini A, Beninati S, Capogrossi MC (2001) Transglutaminase activity is involved in polyamine-induced programmed cell death. Exp Cell Res 271(1):118-129
12. Facchiano AM, Facchiano A, Facchiano F (2003) Active sequences collection (ASC) database: a new tool to assign functions to protein sequences. Nucleic Acids Res 31(1):379-382
13. Facchiano F, Facchiano A, Facchiano AM (2006) The role of transglutaminase-2 and its substrates in human diseases. Front Biosci 11:1758-1773
14. Facchiano F, Deloye F, Doussau F, Innamorati G, Ashton AC, Dolly JO, Beninati S, Facchiano A, Luini A, Poulain B, Benfenati F (2010) Transglutaminase participates in the blockade of neurotransmitter release by tetanus toxin: evidence for a novel biological function. Amino Acids 39(1):257-269
15. Fesus L (1993) Biochemical events in naturally occurring forms of cell death. FEBS Lett 328(1-2):1-5
16. Fesus L, Piacentini M (2002) Transglutaminase 2: an enigmatic enzyme with diverse functions. Trends Biochem Sci 27(10):534-539
17. Forni C, Braglia R, Lentini A, Nuccetelli M, Provenzano B, Tabolacci C, Beninati S (2009) Role of transglutaminase 2 in quercetin-induced differentiation of B16-F10 murine melanoma cells. Amino Acids 36(4):731-738
18. Gismondi A, Lentini A, Tabolacci C, Provenzano B, Beninati S (2010) Transglutaminase-dependent antiproliferative and differentiative properties of nimesulide on B16-F10 mouse melanoma cells. Amino Acids 38(1):257-262
19. Greenberg CS, Birckbichler PJ, Rice RH (1991) Transglutaminases: multifunctional cross-linking enzymes that stabilize tissues. FASEB J 5(15):3071-3077
20. Griffin M, Casadio R, Bergamini CM (2002) Transglutaminases: nature's biological glues. Biochem J 368(Pt 2):377-396
21. Hong S, Hong S, Han B (2011) Overcoming metastatic melanoma with BRAF inhibitors. Arch Pharm Res 34(5):699-701
22. Ishihama Y, Oda Y, Tabata T, Sato T, Nagasu T, Rappsilber J, Mann M (2005) Exponentially modified protein abundance index (emPAI) for estimation of absolute protein amount in proteomics by the number of sequenced peptides per protein. Mol Cell Proteomics 4(9):1265-1272
23. Jemal A, Siegel R, Ward E et al (2009) Cancer statistics. CA Cancer J Clin 59:225
24. Knight CR, Rees RC, Griffin M (1991) Apoptosis: a potential role for cytosolic transglutaminase and its importance in tumour progression. Biochim Biophys Acta 1096(4):312-318
25. Lentini A, Vidal-Vanaclocha F, Facchiano F, Caraglia M, Abbruzzese A, Beninati S (2000a) Theophylline administration markedly reduces hepatic and pulmonary implantation of B16-F10 melanoma cells in mice. Melanoma Res 10(5):435-443
26. Lentini A, Autuori F, Mattioli P, Caraglia M, Abbruzzese A, Beninati S (2000b) Evaluation of the efficacy of potential antineoplastic drugs on tumour metastasis by a computer-assisted image analysis. Eur J Cancer 36(12):1572-1577
27. Lentini A, Provenzano B, Caraglia M, Shevchenko A, Abbruzzese A, Beninati S (2008) Impairment of the metastatic activity of melanoma cells by transglutaminase-catalyzed incorporation of polyamines into laminin and Matrigel. Amino Acids 34(2):251-256
28. Lentini A, Provenzano B, Tabolacci C, Beninati S (2009) Protein-polyamine conjugates by transglutaminase 2 as potential markers for antineoplastic screening of natural compounds. Amino Acids 36(4):701-708
29. Markovic SN, Erickson LA, Rao RD, Weenig RH, Pockaj BA, Bardia A, Vachon CM, Schild SE, McWilliams RR, Hand JL, Laman SD, Kottschade LA, Maples WJ, Pittelkow MR, Pulido JS, Cameron JD, Creagan ET (2007) Malignant melanoma in the 21st century, part 1: epidemiology, risk factors, screening, prevention, and diagnosis. Mayo Clin Proc 82(3):364-380
30. Maurer G, Tarkowski B, Baccarini M (2011) Raf kinases in cancer-roles and therapeutic opportunities. Oncogene 30(32):3477-3488
31. Mehta K, Kumar A, Kim HI (2010) Transglutaminase 2: a multi-tasking protein in the complex circuitry of inflammation and cancer. Biochem Pharmacol 80(12):1921-1929
32. Mycek MJ, Clarke DD, Neidle A, Waelsch H (1959) Amine incorporation into insulin as catalyzed by transglutaminase. Arch Biochem Biophys 84:528-540
33. Piacentini M, Martinet N, Beninati S, Folk JE (1988) Free and protein-conjugated polyamines in mouse epidermal cells. Effect of high calcium and retinoic acid. J Biol Chem 263(8):3790-3794
34. Sambrook J, Fritsch EF, Maniatis T (1989) Molecular cloning: a laboratory manual, 2nd edn. Cold Spring Harbor Laboratory, Cold Spring Harbor
35. Singh RK, Liang D, Gajjalaiahvari UR, Kabbaj MH, Paik J, Gunjan A (2010) Excess histone levels mediate cytotoxicity via multiple mechanisms. Cell Cycle 9(20):4236-4244
36. Sosman JA, Puzanov I (2006) Molecular targets in melanoma from angiogenesis to apoptosis. Clin Cancer Res 12(7):2376s-2383s
37. Tabolacci C, Lentini A, Provenzano B, Beninati S (2012) Evidences for a role of protein cross-links in transglutaminase-related disease. Amino Acids 42:975-986
38. Walther DJ, Peter JU, Winter S, Höltje M, Paulmann N, Grohmann M, Vowinckel J, Alamo-Bethencourt V, Wilhelm CS, Ahnert-Hilger G, Bader M (2003) Serotonylation of small GTPases is a signal transduction pathway that triggers platelet alpha-granule release. Cell 115(7):851-862
39. Wigler M, Sweet R, Sim GK, Wold B, Pellicer A, Lacy E, Maniatis T, Silverstein S, Axel R (1979) Transformation of mammalian cells with genes from procaryotes and eucaryotes. Cell 16:777-785